Tobacco and Vapes Bill

Baroness Morgan of Drefelin Excerpts

2nd reading
Wednesday 23rd April 2025 Lords Chamber

[Baroness Morgan of Drefelin (Lab)]

My Lords, I am delighted to participate in this Second Reading debate. I feel pretty clear about what we are trying to do here. This is a forward-looking Bill. It is about creating opportunities for the future, to have the next generations come through free from the dreadful impacts of tobacco on their lives. The Bill is about reducing the harms associated with tobacco and taking a broad view about that. I can understand why a trip to William Morris would—

[Lord Vaizey of Didcot (Con)]

Philip Morris.

[Baroness Morgan of Drefelin (Lab)]

Philip. I should not say William Morris, I rather like William Morris. I understand why such a trip would prompt these questions, which is what we are trying to do. I think the Bill is forward-looking, focused, proportionate and well balanced.

I want to talk, as the noble Baroness, Lady Thornton, did very movingly, about the impact that smoking has had on my family. I do not know whether I would define myself as a smoker. I certainly smoked when I was a rebellious teenager, but my family was terribly affected by the impact of smoking. My father was diagnosed with lung cancer when I was a teenager, which caused immense hardship for my family, propelled me and my sisters on to the free school meals list, queuing up with all the other children in the special school meal queue in the way we used to in the past. Both my parents went on to die prematurely of smoking-related cancer. It has been a terrible blight on my family and many thousands of families in this country. So, I am hugely in favour of the Bill.

I have enjoyed listening to colleagues from all sides of the House looking back at the journey we have been on to get here, the different debates we had in 2006 that looked at advertising and so on. We have come such a long way and it has been in the face of enormous opposition. To add my anecdote to the journey, when I first came into this House in 2004, smoking cigars and pipes in the Peers’ Guest Room was considered absolutely acceptable. As the day went by, you might bring a guest in and gradually the height of the smoke would descend to such a level that by about 5 pm you could not go in there without a gas mask. We have seen such an enormous amount of progress in tackling the blight of tobacco.

People think that tobacco—smoking—just affects the lungs, but I served as the chief executive of a breast cancer charity for a few decades and, over those years, I have seen the evidence building to show that smoking causes breast cancer as well as lung cancer and all the other impacts that we know about. Cancer Research UK now says that it causes around 2,200 breast cancers a year. So, we need to be mindful that evidence is unfolding all the time about the impact of smoking on our health.

We have heard that around four in 10 cancers in the UK are preventable and the biggest step forward we could take to prevent cancers would be to reduce cancers caused by smoking. We know that vaping, as we have heard, provides important assistance to those who want to quit smoking, and it is absolutely right that the Bill takes that into account. We know that a lot of the marketing and so on, as the noble Lord, Lord Stevens, so clearly demonstrated, is targeted at children.

I close by saying that I fully support those aspects of the Bill. I really congratulate the Government on taking seriously the terrible issues around single-use vapes. Only two weeks ago, I was in a children’s playground looking after a great-nephew. He said to me, “Do you know what? You can find a red box that can make smoke come out of your mouth—sweet smoke. It’s really great”. He is six, and he found a single-use vape in the bushes in the park and had a go on it. We do not want to see that as the norm in our society. This Bill is about the future and the kind of future that we want for our young people—I support it wholeheartedly.

Prisons: Health Services

Baroness Morgan of Drefelin Excerpts

Tuesday 14th January 2025 Lords Chamber

Asked by

[Baroness Morgan of Drefelin]

To ask His Majesty’s Government what assessment they have made of the provision of health services in prisons.

[The Parliamentary Under-Secretary of State, Department of Health and Social Care (Baroness Merron) (Lab)]

My Lords, a full health needs assessment for every prisoner is undertaken at least every three years by NHS England, which then updates service specifications and commissions appropriate services to ensure that the health needs of offenders are being met. All 19 health service specifications for prisons and other detention environments are currently being updated to ensure that they remain fit for purpose and are expected to be published by March 2026.

[Baroness Morgan of Drefelin (Lab)]

My Lords, I thank my noble friend for her Answer. I have heard first hand, through the work of the charities the Prison Reform Trust and Revolving Doors, about the challenging and degrading experience that some prisoners have had trying to access healthcare. Does the Minister agree that there is a huge opportunity to make progress here with the development of better facilities in new prisons? Does she also agree that it be would a positive thing to include prison healthcare services in ICBs’ commissioning to ensure that people in secure settings have access to the advances and developments that are available in the community?

[Baroness Merron (Lab)]

I certainly agree with my noble friend that there are huge opportunities to improve healthcare for prisoners. On new prison design, I reassure her that all prison design will be fit for purpose because medical architects will be commissioned. That new design includes, for example, medical cells so that as many healthcare needs as possible can be met in prison. On my noble friend’s point about ICBs, it is a retained service, so it is not currently delegated to ICBs. It is the responsibility of health and justice commissioners to collaborate closely with ICBs to ensure continuity of care. The electronic referral service means that patients in prison can have access to the developments to which others in the community have access.

Puberty-suppressing Hormones

Baroness Morgan of Drefelin Excerpts

Monday 16th December 2024 Lords Chamber

[Baroness Merron (Lab)]

I very much welcome the generous and supportive comments of the noble Baroness, Lady Fox, in respect of the Secretary of State’s Statement. I am grateful for those. I note that she finds the reference to “uncapped” scary. I presented it as the way to gather the widest amount of relevant evidence, because that is a clinical trial; that is what is so important. The reason it is being done is that there is insufficient evidence and there has not been such a trial, and we need to do one for this particular situation.

In respect of meeting charities and others, the Secretary of State has been very keen to—what I would call—reset the relationship with various groups which all have different sets of thoughts on this. I have joined him in those meetings. He has also been meeting those with lived experience. We continue to do so. We have wanted to detoxify the debate, and those meetings have helped immensely. We will continue to have that listening ear.

[Baroness Morgan of Drefelin (Lab)]

My Lords, I too welcome the Statement. The tone, as we have already heard, has been absolutely right. Thinking about the clinical trial, I would like to know a little more about the timing. If we are intending to run a clinical trial that is going to be looking at efficacy and safety, it will not be an easy trial to run and it is going to take some time. It would be really welcome if the Minister could keep the House informed, which she has already promised to do.

I am particularly interested in hearing the Minister’s view on the following point. It is really important to get this clinical trial on the puberty blockers going, but we also need to understand the value and the evidence supporting all the other interventions too—the psychosocial support, the psychological support, and all the other interventions—so that it is not just this clinical trial but a broad understanding of what really helps these young people. `

[Baroness Merron (Lab)]

My noble friend is right to raise the second point. It is a whole range of interventions, and that is certainly something that we have very much in mind for consideration, for the reasons that we have heard in the Chamber this evening and the points that my noble friend makes. In respect of timings, it is a planned pathway study and that includes a clinical trial component. It is, as I said, to build evidence. I am glad to say that it remains on track to commence recruitment early in 2025, but only after there has been ethical approval. When that is granted, that is when the final study protocol will be ready, and I know that noble Lords will have a lot of interest in that. We will be issuing further updates in early 2025, and if there are any particular questions, noble Lords are very welcome to raise them with me.

Health: Quad-demic

Baroness Morgan of Drefelin Excerpts

Tuesday 10th December 2024 Lords Chamber

Asked by

[Baroness Morgan of Drefelin]

To ask His Majesty’s Government what steps they are taking to reduce the impact of a potential “quad-demic”, involving high prevalence of influenza, respiratory syncytial virus, COVID-19 and norovirus, following the warning of Professor Sir Stephen Powis, the NHS national medical director.

[The Parliamentary Under-Secretary of State, Department of Health and Social Care (Baroness Merron) (Lab)]

My Lords, levels of hospital admissions due to flu and norovirus are higher, while Covid hospitalisation rates are lower and RSV hospitalisation rates are about the same as the same time last year. The impact of these infectious diseases can be reduced through our annual vaccination programmes for flu and Covid-19, as well as the new year-round vaccination programme for RSV, and by observing good hygiene measures. Some 16.6 million flu vaccinations, 9.3 million Covid-19 vaccinations and 1.2 million RSV vaccinations have been delivered so far this winter.

[Baroness Morgan of Drefelin (Lab)]

My Lords, I thank my noble friend the Minister for that comprehensive Answer. I have to say that “quad-demic” was a new phrase for me and so I was very keen to understand what the Minister made of the announcements from the NHS national medical director, Sir Stephen Powis. From my point of view, it is vital that we learn the lessons of the last pandemic and I know a huge amount of work is being done to understand the implications of the recommendations from Module 1 of the inquiry. But, as I understand it from Sir Stephen’s announcement, the uptake of NHS vaccine programmes is much lower than last year, so I am concerned for us to be reassured that if uptake does not improve in the run-up to Christmas, we are ready and we have learned the lessons from last time and we will not panic and start making foolish decisions about PPE acquisition, for example.

[Baroness Merron (Lab)]

We are absolutely committed to learning the lessons from Covid in order to build resilience. The recommendations of the independent review of procurement by Nigel Boardman have already been implemented and a Covid Counter-Fraud Commissioner has already been appointed to scrutinise contracts to learn the lessons and recover money for taxpayers. Professor Sir Stephen Powis, who I have spoken to about this, was not suggesting that there is a pandemic but more that four infectious diseases are coalescing to create a situation and that vaccination is crucial. His comments were a call to the public to get vaccinated, which I also endorse.

NHS: Breast Screening Programme

Baroness Morgan of Drefelin Excerpts

Tuesday 3rd September 2024 Lords Chamber

Asked by

[Baroness Morgan of Drefelin]

To ask His Majesty’s Government what assessment they have made of the take-up of the NHS breast screening programme.

[The Parliamentary Under-Secretary of State, Department of Health and Social Care (Baroness Merron) (Lab)]

Breast cancer survival rates have improved by 41% since the mid-1970s and 86% of women survive their cancer beyond five years. I pay tribute to NHS staff and to my noble friend Lady Morgan for making such a contribution to these improvements. Take-up of breast screening is just below 70%, and NHS England has developed a national uptake improvement plan, including expanding access to screening, reducing inequalities, improving IT systems and ensuring that communications are inclusive and accessible to all.

[Baroness Morgan of Drefelin (Lab)]

I thank my noble friend for that very kind and generous Answer. As we know, screening uptake has been in decline for more than 10 years now. There is no NHS region that has met its 70% minimum standards since 2019-20. Importantly, uptake for women on their first invite is really worrying. Will the Minister commit to keep feet to the fire on this issue, and work closely with the department and NHS England to press down on any potential complacency because breast cancer outcomes have improved so much? Screening is a simple way to stop women dying of breast cancer, and it is not rocket science. Please can we do all we can to improve uptake?

[Baroness Merron (Lab)]

My noble friend makes a very clear and definite point about the link between breast screening and outcomes. I certainly can give her the assurance that we will continue to seek to drive up rates of breast cancer screening. It is important to say that the reason for the take-up not improving as one might have hoped since Covid is multifactored and complex, as I am sure she understands. We all know that research shows that women are more likely to attend breast screening if it is in a unit that is easy to get to, if it is convenient, and if we can help women to get over the problems of fear of the test, awkwardness or embarrassment. I give my noble friend the assurance that the NHS is working on understanding all that, and all that will be in collaboration with charities and key stakeholders.

NHS Blood and Transplant Service: Blood Stocks

Baroness Morgan of Drefelin Excerpts

Tuesday 30th July 2024 Lords Chamber

[Baroness Merron (Lab)]

The lessons-learned exercise started from day one—we are not waiting for the end of the alert. The approach that has been taken is to increase the number of appointment slots available, to launch new and innovative campaigns, and to seek to reduce the use of O-negative blood. On all these levels, there has been a tremendous response from the public and clinicians, and from all stocks. Even if we put the cyberattack to one side, it is certainly the case that collections of blood have been lower in recent months due to the impact of sporting events, bank holidays and the weather. All of these would have been manageable; it is the cyberattack that tipped the service over—by that I mean “over” to the point where it is now.

[Baroness Morgan of Drefelin (Lab)]

My Lords, I am delighted that my noble friend is looking at resilience with respect to the supply of universal O-group blood. Is she concerned that it could be indicative of the pressure that pathology services have been under for many years? If we see cyberattacks, we obviously have to be resilient to those, but we also need to be resilient in the strength of the pathology services across our NHS, so that when you have unusual happenings such as this, there is some back-up. Will she consider that when she looks at the resilience question?

[Baroness Merron (Lab)]

I thank my noble friend. That is a very important point and I will consider it in our deliberations. It is worth saying on resilience that work was already in place—for example, new centres are planned to be opened in Brixton and Brighton. I make that point not just because of expanding capacity but because the location of them will widen the range of donors. We absolutely need to continue. That is why I have asked the chief executive and the chair to come back to me with their plans to make us even more resilient.